This article contains data on the allele and genotype frequency for single nucleotide polymorphisms (SNPs) in candidate genes CHRNA5 (rs16969968, rs17408276, rs680244) CHRNA3 (rs6495307, rs12914385) NRXN1 (rs10865246, rs1882296, rs985919) and HTR2A (rs6311, rs6313) previously evaluated as genetic risk variants for cigarette smoking at an early age and relapse to smoking cessation treatment P erez-Rubio et al., 2018. These SNPs were selected due to previous associations in other populations, including Mexican Mestizos. Smokers were classified according to the age at onset, cigarettes per day, nicotine dependence, COPD status and therapy received.
Data
A descriptive table (Table 1) showing characteristics on the single nucleotide polymorphisms (SNPs) is included, these comprise gene location, alleles (change/minor), chromosome position, minor allele frequency and gene consequence when it applies.
Genotype frequencies for 10 SNPs in the candidate genes CHRNA5 (rs16969968, rs17408276, rs680244), CHRNA3 (rs6495307, rs12914385), NRXN1 (rs10865246, rs1882296, rs985919) and HTR2A (rs6311, rs6313) were evaluated in the participation of smoking-related variables in Mexican Mestizo smokers and their characteristics are described in Tables 2e5.   Specifications table   Subject area Genomic medicine More specific subject area Genetic epidemiology Type of data Tables.
How data was acquired
Smoking pattern survey, allelic discrimination assay by real-time PCR (Applied Biosystems, Foster City, CA, USA) Data format Filtered and analyzed.
Experimental factors
Peripheral blood sample, DNA extraction by BDtract DNA isolation kit (Maxim Biotech, Inc. San Francisco, California, USA).
Experimental features
Genotyping was performed using 3 mL of DNA at 15 ng/mL concentration and TaqMan probes (Applied Biosystems Foster City CA, USA). In each template, we included 3 non-template controls, and 1% of the samples were genotyped in duplicate as an allele assignment control. 2. Experimental design, materials, and methods
Participants
Subjects with 30 years, men and women. To determine Mexican Mestizo ancestry, subjects were asked about their parents and grandparents ancestry and not belong to an indigenous group (See Table 6 ).
Smokers recruited from the Smoking Cessation Support Clinic of the Department of Investigation in Tobacco Consumption and COPD at the Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas (INER) in Mexico City, with the following criteria: individuals who started smoking in adolescence (<18 years) were defined as early smokers (ES) or those who started smoking in adulthood (18 years) defined as late smokers (LS); these subjects have been recruited previously in our research group [2, 3] . 
Smoking-related variables
A survey with smoking-related variables was assessed to daily smokers. They were asked about their smoking pattern by cigarette smoked per day (cpd), classified as heavy smokers (HS, 20 cpd), moderate smokers (MS, 11e19 cpd) and light smokers (LIS, 10 cpd). Level on nicotine dependence was measured by Fagerstr€ om Test for Cigarette Dependence (FCTD), classified as high (HD), moderate (MD) and low dependence (LD) by their score as 7 to 10, 5 and 6, and less than 4, respectively. According to the intervention received by the physicians and psychologists, individuals were classified as only cognitive-behavioral therapy (CBT) without any pharmacological therapy (PT), and CBT plus any PT, which could include nicotine replacement therapy and/or Bupropion and Varenicline.
COPD diagnosis
As a requirement to attend the cessation sessions, participants were asked to perform spirometry in order to diagnose smoking-related diseases as chronic obstructive pulmonary disease (COPD). The diagnosis was done a physician and was based on patient medical history, physical examination, and spirometry data, with American Thoracic Society criteria. COPD was defined as an FEV1/FVC ratio of less than 70% in post-bronchodilator maneuver.
DNA extraction
A 15 mL peripheral blood sample in tubes with EDTA was obtained from each participant through forearm venipuncture. The DNA extraction was performed using BDtract DNA isolation kit (Maxim Biotech, Inc. San Francisco, California, USA) and later was quantified by spectrophotometry with a NanoDrop 2000 (Thermo Scientific, DE, USA). DNA samples with a concentration >100 ng/mL and purity with a 260/280 relation 2. 
SNP selection
These 10 SNPs were selected because they were previously evaluated with cigarette smoking or with nicotine dependence in Mexican mestizo smokers [1] .
Genotyping
Genotyping was performed using a real-time PCR (7300 Real-Time PCR system, Applied Biosystems, Foster City, CA, USA) based allelic discrimination assay using 3 mL of DNA at 15 ng/mL concentration and TaqMan probes (Applied Biosystems Foster City CA, USA). In each template, were included 3 nontemplate controls, and 1% of the samples were genotyped in duplicate as an allele assignment control. Detection Software (SDS v. 1.4, Applied Biosystems). VIC™ and FAM™ dyes were used for alleles A and B, respectively. 
Genotype frequency
All smokers in the study were compared by full genotype frequency according to the smokingrelated variables.
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